Using human genetics to understand the causes and consequences of circulating cardiac troponin I in the general population
By
Marta R Moksnes,
Helge Rosjo,
Anne Richmond,
Magnus N Lyngbakken,
Sarah E Graham,
Ailin Falkmo Hansen,
Brooke N. Wolford,
Sarah A Gagliano Taliun,
Jonathon LeFaive,
Humaira Rasheed,
Laurent F. Thomas,
Wei Zhou,
Nay Aung,
Ida Surakka,
Nicholas J Douville,
Archie Campbell,
David J Porteous,
Steffen E Petersen,
Patricia B Munroe,
Paul Welsh,
Naveed Sattar,
George Davey Smith,
Lars G. Fritsche,
Jonas B Nielsen,
Bjorn Olav Asvold,
Kristian Hveem,
Caroline Hayward,
Cristen J. Willer,
Ben M Brumpton,
Torbjorn Omland
Posted 05 Sep 2020
medRxiv DOI: 10.1101/2020.09.04.20187401
Circulating cardiac troponin proteins are associated with structural heart disease and predict incident cardiovascular disease in the general population. However, the genetic contribution to cardiac troponin I (cTnI) concentrations and its causal effect on cardiovascular phenotypes is unclear. We combine data from two large population-based studies, the Trondelag Health Study and the Generation Scotland Scottish Family Health Study and perform a genome-wide association study of high-sensitivity cTnI concentrations with 48 115 individuals. We further used two-sample Mendelian randomization to investigate the causal effects of circulating cTnI on acute myocardial infarction and heart failure. We identified 12 genetic loci (8 novel) associated with cTnI concentrations. Associated protein-altering variants highlighted putative functional genes: CAND2, HABP2, ANO5, APOH, FHOD3, TNFAIP2, KLKB1 and LMAN1. Phenome-wide association tests in 1283 phecodes and 274 continuous traits in UK Biobank showed associations between a polygenic risk score for cTnI and cardiac arrhythmias, aspartate aminotransferase 1 and anthropometric measures. Excluding individuals with a known history of comorbidities did not materially change associations with cTnI. Using two-sample Mendelian randomization we confirmed the non-causal role of cTnI in acute myocardial infarction (5 948 cases, 355 246 controls). We found some indications for a causal role of cTnI in heart failure (47 309 cases and 930 014 controls), but this was not supported by secondary analyses using left ventricular mass as outcome (18 257 individuals). Our findings clarify the biology underlying the heritable contribution to circulating cTnI and support cTnI as a non-causal biomarker for acute myocardial infarction and heart failure development in the general population. Using genetically informed methods for causal inference of cTnI helps inform the role and value of measuring cTnI in the general population.
Download data
- Downloaded 194 times
- Download rankings, all-time:
- Site-wide: 102,685
- In epidemiology: 4,198
- Year to date:
- Site-wide: 39,247
- Since beginning of last month:
- Site-wide: 39,247
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!